Merck & Co., Inc. (Merck) is a global research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of products to improve human and animal health. The Company's operations are principally managed on a products basis and consist of two business segments. The Pharmaceutical segment includes human health pharmaceutical products marketed either directly or through joint ventures. These products consist of therapeutic and preventive agents, sold by prescription, for the treatment of human disorders. The Vaccines and Infectious Diseases segment includes human health vaccine products marketed either directly or through a joint venture. These products consist of preventative pediatric, adolescent and adult vaccines, primarily administered at physician offices. Infectious disease products consist of therapeutic agents for the treatment of infection sold primarily to drug wholesalers and retailers, hospitals and government agencies.

View SEC Filings from MRK instead.
Filers who had this stock in their top 10: 101
13F Filers holding this stock: 1682
Aggregate shares on 03/31/2016: 2,051,898,543
Aggregate shares on 12/31/2015: 2,054,510,100
Percent change: -0.13%
Funds creating new positions: 87
Funds Adding to an existing position: 728
Funds closing out their position: 81
Funds reducing their position: 657
Heat Map Ranking for 03/31/2016 53
Heat Map Ranking for 12/31/2015 96
View recent insider trading info

13F Filers holding this stock

Quarter 1: Refresh

Changes in Holdings:

*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Schedule 13D and 13G filings submitted since 03/31/2016

Subscription required

Click here to report any possible errors with this stock listing.

Elevate your investments

or Learn more